How severe is CVE-2023-27874?

CVE-2023-27874 has a CVSS 3.x base score of 9.9, rated critical severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2023-27874 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (68th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-27874?

CVE-2023-27874 primarily affects Ibm Aspera Faspex. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2023-27874?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.

When was CVE-2023-27874 published?

CVE-2023-27874 was published on 2023-03-21 and last updated on 2026-06-17.

CVE-2023-27874

CVE-2023-27874 is a critical-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 9.9. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-611.

Key facts

Severity: Critical (CVSS 3.x base score 9.9)
EPSS exploit prediction: 1% (68th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-611
Affected product: Ibm Aspera Faspex
Published: 2023-03-21
Last modified: 2026-06-17

Description

IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A remote authenticated attacker could exploit this vulnerability to execute arbitrary commands. IBM X-Force ID: 249845.

Frequently asked questions

What is CVE-2023-27874?: IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A remote authenticated attacker could exploit this vulnerability to execute arbitrary commands. IBM X-Force ID: 249845.
How severe is CVE-2023-27874?: CVE-2023-27874 has a CVSS 3.x base score of 9.9, rated critical severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-27874 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (68th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-27874?: CVE-2023-27874 primarily affects Ibm Aspera Faspex. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-27874?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2023-27874 published?: CVE-2023-27874 was published on 2023-03-21 and last updated on 2026-06-17.

References

Affected products (3)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.2:patch_level_1:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.2:patch_level_2:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…
CVE-2022-22497 — High (CVSS 7.5): IBM Aspera Faspex 4.4.1 and 5.0.0 could allow unauthorized access due to an incorrectly computed security token. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-611 (Improper Restriction of XML External Entity Reference (XXE)) vulnerabilities

CVE-2022-22486 — Critical (CVSS 10.0): IBM Tivoli Workload Scheduler 9.4, 9.5, and 10.1 is vulnerable to an XML External Entity Injection (XXE) attack when…
CVE-2019-14678 — Critical (CVSS 10.0): SAS XML Mapper 9.45 has an XML External Entity (XXE) vulnerability that can be leveraged by malicious attackers in…
CVE-2015-9280 — Critical (CVSS 10.0): MailEnable before 8.60 allows XXE via an XML document in the request.aspx Options parameter.
CVE-2018-1000838 — Critical (CVSS 10.0): autopsy version <= 4.9.0 contains a XML External Entity (XXE) vulnerability in CaseMetadata XML Parser that can result…
CVE-2018-1000837 — Critical (CVSS 10.0): UML Designer version <= 8.0.0 contains a XML External Entity (XXE) vulnerability in XML parser for plugins that can…
CVE-2018-1000835 — Critical (CVSS 10.0): KeePassDX version <= 2.5.0.0beta17 contains a XML External Entity (XXE) vulnerability in kdbx file parser that can…

Browse all CWE-611 (Improper Restriction of XML External Entity Reference (XXE)) vulnerabilities →